Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;127(4):716-726.
doi: 10.1002/jso.27153. Epub 2022 Dec 1.

Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma

Laura D Leonard  1 , Laurel Beaty  1   2 , Madeline Thomas  1 , Christopher Quinn  1 , Kathryn L Colborn  1   2 , Thiago B de Araujo  1 , Robert J Torphy  1 , Lia R Assumpção  3 , Kelly Olino  4 , Christina R Studts  5 , Salvador Rodriguez Franco  1   6 , Martin McCarter  1 , Camille Stewart  1 , Ana L Gleisner  1
Affiliations

Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma

Laura D Leonard et al. J Surg Oncol. 2023 Mar.

Abstract

Background: Completion lymph node dissection (CLND) was the standard treatment for patients with melanoma with positive sentinel lymph nodes (SLN) until 2017 when data from the DeCOG-SLT and MLST-2 randomized trials challenged the survival benefit of this procedure. We assessed the contribution of patient, tumor and facility factors on the use of CLND in patients with surgically resected Stage III melanoma.

Methods: Using the National Cancer Database, patients who underwent surgical excision and were found to have a positive SLN from 2012 to 2017 were included. A multivariable mixed-effects logistic regression model with a random intercept for the facility was used to determine the effect of patient, tumor, and facility variables on the risk of CLND. Reference effect measures (REMs) were used to compare the contribution of contextual effects (unknown facility variables) versus measured variables on the variation in CLND use.

Results: From 2012 to 2017, the overall use of CLND decreased from 59.9% to 26.5% (p < 0.0001). Overall, older patients and patients with government-based insurance were less likely to undergo CLND. Tumor factors associated with a decreased rate of CLND included primary tumor location on the lower limb, decreasing depth, and mitotic rate <1. However, the contribution of contextual effects to the variation in CLND use exceeded that of the measured facility, tumor, time, and patient variables.

Conclusions: There was a decrease in CLND use during the study period. However, there is still high variability in CLND use, mainly driven by unmeasured contextual effects.

Keywords: deimplementation; lymph node dissection; melanoma; overuse.

PubMed Disclaimer

References

REFERENCES

    1. May P, Garrido MM, Cassel JB, et al. Palliative care teams' cost-saving effect is larger for cancer patients with higher numbers of comorbidities. Health Aff. 2016;35:44-53.
    1. Antunez AG, Telem DA, Dossett LA. Assessment of surgical specialty societies' choosing wisely recommendations. JAMA Surgery. 2019;154(10):971-973.
    1. Baxi SS, Kale M, Keyhani S, et al. Overuse of health care services in the management of cancer: a systematic review. Med Care. 2017;55(7):723-733.
    1. Niven DJ, Mrklas KJ, Holodinsky JK, et al. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med. 2015;13:255.
    1. Hewitt DB, Merkow RP, DeLancey JO, et al. National practice patterns of completion lymph node dissection for sentinel node-positive melanoma. J Surg Oncol. 2018;118(3):493-500.

MeSH terms

LinkOut - more resources